	Fatty acids metabolic reprogramming and tumor microenvironment in pancreatic cancer: targeting pathways. Clin Exp Med Ehab B, Saleh E. PMID: 42525264 [PubMed - indexed for MEDLINE]
	Definition of Conversion Therapy and Neoadjuvant Therapy for Hepatocellular Carcinoma: A Consensus Guideline from the Japan Liver Cancer Association. Liver Cancer Ichida A, Tateishi R, Hatano E, Taketomi A, Tanabe M, Nouso K, Minami Y, Murakami T, Shimada M, Hasegawa K. PMID: 42524660 [PubMed - as supplied by publisher]
	Systemic therapy for gastroenteropancreatic neuroendocrine neoplasms: current landscape and future directions. Ther Adv Med Oncol So E, Morizane C, Okusaka T. PMID: 42524036 [PubMed - as supplied by publisher]
	Cancer outcomes and biological mechanisms among patients with type 2 diabetes mellitus using glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis. Front Oncol Eze ED, Ntakirutimana L, Terkimbi SD, Walle M, Umar AH, Wondimu DH, Olubiyi MV, Okeke OC, Onaadepo O, Abdulazeez J, Ikwuka DC, Ani EJ, Alagbonsi AI. PMID: 42523690 [PubMed - as supplied by publisher]
	Metabolic comorbidities affect the survival of hepatitis B virus-related hepatocellular carcinoma in Chinese patients: a retrospective cohort study with propensity score matching. Front Oncol Zhou Z, Zheng X, Lin Z, Chen X, Xie M. PMID: 42523603 [PubMed - as supplied by publisher]
	Red and processed meat consumption and the risk of pancreatic cancer: a systematic review and dose-response meta-analysis. Front Nutr Lu Y, Gu M, Zhao Y, Ma L, Wei Y, Liu Z, Wu Y, Fu X, Liang J, Yang L, Su Y, Chen T, Zhang D, Hu F, Hu D, Zhang M. PMID: 42523589 [PubMed - as supplied by publisher]
	Prognostic and Predictive Values of Transcriptomic Signatures in Metastatic Pancreatic Cancer: A Biomarker Analysis of Three French Multicenter Prospective Randomized Controlled Phase 2 Trials (Prodige35, Prodige37 and AFUGEM). Cancer Lett Zhao S, Nicolle R, Taieb J, Dahan L, Abdallah R, Bouché O, Desrame J, Phelip JM, Evesque L, Akouz FK, de Mestier L, Trouilloud I, Malka D, Shen B, Cros J, Laurent-Puig P, Bachet JB. PMID: 42521075 [PubMed - as supplied by publisher]
	Discovery of a prognostic two-lncRNA panel correlated with immune-associated transcripts for forecasting overall survival in pancreatic cancer. Immunobiology Eftekhari H, Safarzadeh A, Babakhanzadeh E, Ghafouri-Fard S. PMID: 42520353 [PubMed - as supplied by publisher]
	Correction: Impact of Hypertrophy-Oriented Resistance Training on Muscle Mass and Quality of Life in Patients with Unresectable Pancreatic Cancer (HY-PANC): Study Protocol for a Randomized Controlled Trial. Curr Protoc Braceras Arias P, Burgos Postigo S, B Alejo L. PMID: 42519871 [PubMed - as supplied by publisher]
	Research advances on tumor-associated macrophages in pancreatic cancer. Biochem Biophys Rep Miao JY, Zhang LQ, He Y, Wang W. PMID: 42519576 [PubMed - as supplied by publisher]
	Dual-Modality SPECT and Viscosity-Responsive AIE Fluorescence Probe for Pancreatic Cancer Diagnosis and Intraoperative Guidance. ACS Omega Zhang K, Chen Q, Huang Q, Qi X, Qin Y, Wang D, Zhu R, Wang G, Ma X. PMID: 42518470 [PubMed - as supplied by publisher]
	Berberine-induced ferroptosis as a novel anti-cancer strategy: Molecular, epigenetic and translational perspectives. EXCLI J Agrawal N, Gupta G, Pandey SN, Rekha A, Vijayan MP, Chellappan DK, Raj Paudal K, Singh SK, Dua K. PMID: 42517086 [PubMed - as supplied by publisher]
	Molecular Imaging in Pancreatic Cancer: Current Applications and Future Perspectives. Pharmaceuticals (Basel) Liu Y, Lan K, Sun Z, Huang W. PMID: 42515759 [PubMed - as supplied by publisher]
	Study on Synergistic Treatment of Pancreatic Cancer by Multiple Small Interfering Ribonucleic Acid Lipid Nanoparticles of Disk Domain Receptor 1, Transforming Growth Factor Î²1, Tumor-Associated Calcium Signal Transduction Protein 2, and Polyligand Proteoglycan 1. Pharmaceutics Wang R, Zeng Y, Zeng Z, Xie T. PMID: 42514856 [PubMed - as supplied by publisher]
	Precision Therapeutics in Pancreatic Cancer: Emerging Targeted, Immune, and Antibody-Drug Conjugate Strategies Exemplified by Adagrasib, Dostarlimab, and Trastuzumab Deruxtecan. J Clin Med Kawczak P, Kawczak K, B. PMID: 42513436 [PubMed - in process]
	Cancer-Associated Fibroblast Heterogeneity and Extracellular Matrix Remodeling as Orchestrators of Drug Resistance in Upper Gastrointestinal Cancers: Insights from Spatial Multi-Omics and Therapeutic Implications. Cancers (Basel) Mirzabeigi Y, Youssef J, Gonzalez J, Martinez T, Avellan R, Wong A, Perez M, Carvajal LL, Abou-Kheir W, Bahmad HF. PMID: 42512419 [PubMed - in process]
	Vitamin D Status and Gastroenteropancreatic Neuroendocrine Neoplasms: Biological Rationale, Clinical Associations and Limitations of Current Evidence. Cancers (Basel) Basiaga B, Rosiek V, Kos-Kud. PMID: 42512408 [PubMed - in process]
	Epidemiological Trends, Inter-Cancer Correlations, and Incidence Projections for 61 Cancer Types in Korea, 1999-2028: A Nationwide Population-Based Study. Cancers (Basel) Jung H, Jung M. PMID: 42512403 [PubMed - in process]
	Pancreatic Acinar Cell Carcinoma: A Rare Pancreatic Malignancy with Distinct Biology and Emerging Therapeutic Opportunities. Cancers (Basel) Farhoud N, Al-Rajabi RMT, Baranda JC, Li H, Zhang W, Paluri RK, Manne A, Dandawate P, Sun W, Kasi A. PMID: 42512378 [PubMed - in process]
	Inflammation-Based Hematological Indices (NLR, PLR, LMR) in Pancreatic Cancer: Implications for Laboratory Diagnostics and Clinical Interpretation. Cancers (Basel) Zawistowska I, Wolszczak-Biedrzycka B, Kukli, Dymicka-Piekarska V, Dorf J. PMID: 42512376 [PubMed - in process]

Articles 1 - 20 / 61023

Page 1 of 3052



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy